Literature DB >> 8497913

Early versus late acute renal allograft rejection: impact on chronic rejection.

G P Basadonna1, A J Matas, K J Gillingham, W D Payne, D L Dunn, D E Sutherland, P F Gores, R W Gruessner, J S Najarian.   

Abstract

We studied the effect of acute renal allograft rejection and its timing on the development of chronic rejection and subsequent graft loss. Between January 1, 1987 and April 30, 1991, 424 patients at the University of Minnesota received a primary kidney transplant (minimum follow-up, 1 year). Patients were subdivided by donor source, presence or absence of acute rejection, and the timing of acute rejection onset (early, < or = 60 days vs. late, > 60 days post-transplant). For living donor (LD) transplant recipients (n = 219), the incidence of chronic rejection is 0.8% in those who had no acute rejection (n = 130), 20% in those with acute rejection < or = 60 days (n = 59) (P < 0.001 vs. no acute rejection), and 43% in those with acute rejection > 60 days (n = 30) (P < 0.001 vs. no acute rejection, P = 0.04 vs. early acute rejection). For cadaver (CAD) transplant recipients (n = 205), the incidence of chronic rejection is 0% in those who had no acute rejection (n = 109), 36% in those with acute rejection < or = 60 days (n = 69) (P < 0.001 vs. no acute rejection), and 63% in those with acute rejection > 60 days (n = 27) (P < 0.001 vs. no acute rejection, P = 0.03 vs. early acute rejection). For both LD and CAD recipients, no grafts have been lost to chronic rejection among those who did not first have at least 1 acute rejection episode. In contrast, 23 patients with acute rejection have had graft loss to chronic rejection. For both LD and CAD recipients, those with > 1 acute rejection episode had significantly more chronic rejection than those with only 1 rejection (P < 0.05). There was no significant difference in the incidence of chronic rejection based on whether the first acute rejection episode was steroid resistant or steroid responsive. We conclude that acute rejection is strongly related to the development of biopsy-proven chronic rejection and subsequent graft loss. Patients undergoing their first acute rejection episode > 60 days (vs. < or = 60 days) have an increased incidence of chronic rejection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8497913     DOI: 10.1097/00007890-199305000-00007

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  30 in total

1.  Abrogation of chronic rejection in a murine model of aortic allotransplantation by prior induction of donor-specific tolerance.

Authors:  V Subbotin; H Sun; A Aitouche; L A Valdivia; J J Fung; T E Starzl; A S Rao
Journal:  Transplantation       Date:  1997-09-15       Impact factor: 4.939

Review 2.  Current landscape for T-cell targeting in autoimmunity and transplantation.

Authors:  Daniel R Getts; Sushma Shankar; Emily M L Chastain; Aaron Martin; Meghann Teague Getts; Kathryn Wood; Stephen D Miller
Journal:  Immunotherapy       Date:  2011-07       Impact factor: 4.196

3.  Does mycophenolate mofetil decrease the recurrent acute rejection in renal transplant recipients.

Authors:  Aneesh Srivastava; Vishwajeet Singh; Devendra Kumar; Anant Kumar; R K Sharma
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

Review 4.  Chronic rejection and late renal allograft dysfunction.

Authors:  J Laine; C Holmberg; P Häyry
Journal:  Pediatr Nephrol       Date:  1996-04       Impact factor: 3.714

Review 5.  Effectiveness and safety of calcineurin inhibitor withdrawal in kidney transplantation: a meta-analysis of randomized controlled trials.

Authors:  Hongwei Bai; Yeyong Qian; Bingyi Shi; Zhen Wang; Gang Li; Yu Fan; Ming Yuan; Lupeng Liu
Journal:  Clin Exp Nephrol       Date:  2015-03-29       Impact factor: 2.801

6.  Inhibitors of mTOR and risks of allograft failure and mortality in kidney transplantation.

Authors:  T Isakova; H Xie; S Messinger; F Cortazar; J J Scialla; G Guerra; G Contreras; D Roth; G W Burke; M Z Molnar; I Mucsi; M Wolf
Journal:  Am J Transplant       Date:  2012-10-01       Impact factor: 8.086

7.  Nephron supply is a major determinant of long-term renal allograft outcome in rats.

Authors:  H S Mackenzie; S G Tullius; U W Heemann; H Azuma; H G Rennke; B M Brenner; N L Tilney
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

Review 8.  Corticosteroid avoidance in pediatric renal transplantation: can it be achieved?

Authors:  Jayakumar R Vidhun; Minnie M Sarwal
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

Review 9.  Advances in diagnostics for transplant rejection.

Authors:  Michael Nasr; Tara Sigdel; Minnie Sarwal
Journal:  Expert Rev Mol Diagn       Date:  2016-10       Impact factor: 5.225

10.  The role of basiliximab in the evolving renal transplantation immunosuppression protocol.

Authors:  Paola Salis; Chiara Caccamo; Roberto Verzaro; Salvatore Gruttadauria; Mary Artero
Journal:  Biologics       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.